ClinicalTrials.gov
public full text
Public Domain
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
The Primary Objective: To observe and determine the safety and tolerance of allogeneic hepatocyte transplantation in patients with liver cirrhosis and to establish the maximum-tolerated dose (MTD) and evaluate the dose-limiting toxicities (DLTs). The Secondary Objective: To observe the therapeutic efficacy of allogeneic hepatocyte transplantation for liver cirrhosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation#1137512
- Hepatocyte Transplantation for Acute Decompensated Liver Failure#1351565
- Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration#841991
- Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure#1280414
- Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure#121407
Record · ID 1260084
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive